Production of therapeutic proteins with baculovirus expression system in insect cell

Institute of Biotechnology, Wonkwang University, Iksan, Korea
Entomological Research (Impact Factor: 0.33). 11/2008; 38(s1):S71 - S78. DOI: 10.1111/j.1748-5967.2008.00177.x

ABSTRACT Recombinant DNA technology has a major advantage in that it is capable of producing specific therapeutic proteins on demand in a heterologous expression system. The extent of this notion can be understood when one considers how crucial such proteins are, and how problematic the economical and safe production of such proteins are. Therapeutic recombinant protein production is a fundamental aspect of 21st century biotechnology industries. The improved therapeutic recombinant protein expression systems that use prokaryotic and eukaryotic cells have enabled the development of a multi-billion dollar industry. Among the variety of available heterologous expression systems, the baculovirus-based insect cell expression system has been utilized frequently for the high-level production of therapeutic recombinant proteins. Thus, the baculovirus expression system has been recognized as one of the most powerful expression technologies for production, by virtue of the achievable amount and purity, and the ease of the eukaryotic production process. The majority of therapeutic proteins are glycoproteins originating from humans. The insect-based expression system harbors glycosylation processing pathways, which constitute an advantage over other prokaryotic systems that lack glycosylation. However, there are several drawbacks which must be circumvented in order to establish an efficient system for the production of recombinant proteins. This review presents a brief overview of the perspective, particularly the glycosylation aspect, of the production of therapeutic recombinant proteins via a baculovirus-based insect cell expression system.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this paper was to study the effect of spent medium recycle on proliferation, metabolism and baculovirus production by the Spodoptera exigua Se301 cell line when grown in batch suspension cultures in Ex-Cell 420 serum-free medium. The results showed that the recycle of 20% of spent medium from a culture in mid-exponential growth phase improved growth relative to a control culture grown in fresh medium. Although both glucose and glutamine were still present at the end of the growth phase, glutamate was always completely exhausted. The pattern of the specific glucose and lactate consumption and production rates, as well as the specific glutamine and glutamate consumption rates, suggests a metabolic shift at spent medium recycle values of over 60%, with a decrease in the efficiency of glucose utilization and an increase in glutamate consumption to fuel energy metabolism. Baculovirus infection provoked a change in the metabolic pattern of Se301 cells, although a beneficial effect of spent medium recycle was also observed. Both growth rate and maximum viable cell density decreased relative to uninfected cultures. The efficiency of glucose utilization was dramatically reduced in those cultures containing the lowest percentages of spent medium, whereas glutamine and glutamate consumption was modulated, thereby suggesting that infected cells were devoted to virus replication retaining their ability to incorporate the nutrients required to support viral replication. Recycle of 20% of spent medium increased baculovirus production by around 90%, thus showing the link between cell growth and baculovirus production.
    Journal of Microbiology and Biotechnology 09/2013; · 1.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bernd Hoevel, Application Technology Development Leader, Alternative Energy, and Alain Sagnard, Senior R&D Engineer, at The Dow Chemical Company describe how the company's foam core material and epoxy resin systems can help manufacture lighter, stronger wind turbine blades.
    Reinforced Plastics 07/2011; 55(4):38-41.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer is a commonly diagnosed cancer in the world. Monoclonal antibody (mAb) CO17-1A recognizes the tumor-associated antigen GA733, a cell surface glycoprotein highly expressed in colorectal carcinoma cell, which is considered to be applicable for diagnosis and therapeutic treatment against colorectal cancer. In addition antibodies are glycoproteins, efficiently recognize and eliminate specific pathogenic and disease antigens. We have currently established baculovirus insect cell expression system to produce anti-colorectal cancer mAb CO17-1A. In this study, mAb CO17-1A was expressed in the transgenic insect cell line SfSWT4, in which glycosylation processing pathway has been humanized. Immunoblot confirmed that mAb CO17-1A properly expressed in SfSWT4 insect cells. mAb CO17-1A was purified using protein G affinity column. In addition, MALDI-TOF verified that the mAb CO17-1A fused to KDEL, endoplasmic reticulum (ER) retention signal (mAb CO17-1AK) had high mannose type of glycan structure. Migration assay showed that insect cell-derived mAb CO17-1AK (mAbI CO17-1AK) with high mannose type of glycan structure was effective as mammalian-derived mAb CO17-1A (mAbM CO17-1A) in inhibition of metastasis. Kinetic analysis of antigen-antibody interaction using Surface Plasmon Resonance (SPR) confirmed that mAbI CO17-1AK is efficient to interact with antigen GA733 as mAbM CO17-1A. These results suggest that the insect cell expression system with the SfSWT4 possibly can be used as a useful alternative way to produce full-size mAb for cancer immunotherapy.
    Entomological Research 01/2014; 44(1). · 0.33 Impact Factor


Available from
May 19, 2014